{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:22:33Z","timestamp":1762842153161,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.ctarc.2017.11.007","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T19:30:30Z","timestamp":1512156630000},"page":"30-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy \u2013 Minimum 5 years follow up"],"prefix":"10.1016","volume":"14","author":[{"given":"Shagun","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punita","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saibish","family":"Kumar EP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shalini","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J. Maria","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaleen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"NIH News Advisory; NCI Issues Clinical Announcements on Cervical Cancer: Chemotherapy plus Radiation Therapy Improves Survival, 1999, 99.","key":"10.1016\/j.ctarc.2017.11.007_bib1"},{"issue":"15","key":"10.1016\/j.ctarc.2017.11.007_bib2","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2017.11.007_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2017.11.007_bib4","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib5","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","article-title":"Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma","volume":"340","author":"Keys","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2017.11.007_bib6","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.1999.17.5.1339","article-title":"Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjuvant to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study","volume":"17","author":"Whitney","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","article-title":"Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis","volume":"358","author":"Green","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2017.11.007_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/clon.2002.0076","article-title":"Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer \u2013 a meta-analysis","volume":"14","author":"Lukka","year":"2002","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2017.11.007_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2017.01.033","article-title":"Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervixcancer: a systematic review and meta-analysis","volume":"145","author":"Datta","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib10","first-page":"CD008285","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis","volume":"1","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ctarc.2017.11.007_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","article-title":"Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer","volume":"29","author":"Maduro","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2017.11.007_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-8140(03)00197-X","article-title":"A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer","volume":"68","author":"Kirwan","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0020-7292(98)00234-3","article-title":"FIGO staging of gynecologic cancer","volume":"64","author":"Pecorelli","year":"1999","journal-title":"Int. J. Gynecol. Obstet."},{"year":"1985","author":"Chassagne","series-title":"Dose and Volume Specification for Reporting Intracavitary Therapy in Gynecology","key":"10.1016\/j.ctarc.2017.11.007_bib14"},{"key":"10.1016\/j.ctarc.2017.11.007_bib15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib16","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0360-3016(81)90011-0","article-title":"Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival","volume":"7","author":"Carde","year":"1981","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0360-3016(87)90076-9","article-title":"Effect of cisplatin resistance on cellular radiation response","volume":"13","author":"Wallner","year":"1987","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0360-3016(95)00041-V","article-title":"Complicating issues in complication reporting","volume":"31","author":"Peters","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0360-3016(94)90416-2","article-title":"Analysis of the probability and risk of cause-specific failure","volume":"29","author":"Caplan","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0360-3016(95)00262-W","article-title":"Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment \u2026 now!","volume":"32","author":"Bentzen","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0167-8140(93)90005-S","article-title":"Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system","volume":"28","author":"Pedersen","year":"1993","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/0360-3016(95)00118-I","article-title":"Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix","volume":"32","author":"Eifel","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib23","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1200\/JCO.2002.20.4.966","article-title":"Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix","volume":"20","author":"Pearcey","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0360-3016(94)90387-5","article-title":"Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of cervix","volume":"29","author":"Pedersen","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clon.2008.03.001","article-title":"Long-term survival and late toxicity after chemoradiotherapy for cervical cancer; the Addenbrooke's experience","volume":"20","author":"Tan","year":"2008","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib26","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/1097-0142(19920415)69:8<2124::AID-CNCR2820690819>3.0.CO;2-D","article-title":"Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A patterns of care study","volume":"69","author":"Lanciano","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(02)03939-1","article-title":"Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables","volume":"55","author":"Ferrigno","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib28","first-page":"E7","article-title":"Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India","volume":"92","author":"Saibishkumar","year":"2005","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clon.2005.09.001","article-title":"Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects","volume":"18","author":"King","year":"2006","journal-title":"Clin. Oncol. (R Coll. Radiol.)"},{"key":"10.1016\/j.ctarc.2017.11.007_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.1997.4721","article-title":"A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix","volume":"66","author":"Tseng","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib31","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.1999.17.7.2055","article-title":"Chemoradiation and adjuvant chemotherapy in cervical cancer","volume":"17","author":"Wong","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib32","first-page":"249","article-title":"The effect of randomized trial of hyperthermo-radiochemotherapy for carcinoma of the cervix","volume":"24","author":"Hongwei","year":"1997","journal-title":"Chin. J. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1200\/JCO.2004.07.197","article-title":"Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group Trial (RTOG) 90-01","volume":"22","author":"Eifel","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clon.2008.10.014","article-title":"Clinical outcome for chemoradiotherapy in carcinoma of the cervix","volume":"21","author":"Spensley","year":"2009","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.ctarc.2017.11.007_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00066-013-0365-7","article-title":"Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer","volume":"189","author":"Georg","year":"2013","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.ijrobp.2012.01.064","article-title":"Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis","volume":"84","author":"Gondi","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib38","first-page":"CD007291","article-title":"Vaginal dilator therapy for women receiving pelvic radiotherapy","author":"Miles","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ctarc.2017.11.007_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/cncr.24811","article-title":"Pelvic fractures after radiotherapy for cervical cancer: implications for survivors","volume":"116","author":"Schmeler","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0360-3016(95)00546-B","article-title":"Femoral neck fracture following groin irradiation","volume":"32","author":"Grigsby","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib41","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2007.08.005","article-title":"Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors","volume":"70","author":"Oh","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0167-8140(03)00128-2","article-title":"Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy","volume":"68","author":"Ogino","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib43","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ygyno.2006.06.038","article-title":"Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures","volume":"103","author":"Ikushima","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mpo.10338","article-title":"Radiation-therapy effects on bone density","volume":"41","author":"Hopewell","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.clon.2010.06.002","article-title":"Substantial improvement in UK cervical cancer survival with chemoradiotherapy: results of a Royal College of Radiologists' audit","volume":"22","author":"Vale","year":"2010","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.ctarc.2017.11.007_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1097-0142(19840715)54:2<235::AID-CNCR2820540210>3.0.CO;2-H","article-title":"Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications","volume":"54","author":"Perez","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L","article-title":"Second primary cancer after treatment for cervical cancer.\u00a0An international cancer registries study","volume":"76","author":"Kleinerman","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0360-3016(99)00111-X","article-title":"Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation","volume":"44","author":"Perez","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/1097-0142(19850301)55:5<956::AID-CNCR2820550507>3.0.CO;2-V","article-title":"Analysis of results of radiation therapy for Stage II carcinoma of the cervix","volume":"55","author":"Montana","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2017.11.007_bib50","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0360-3016(94)90501-0","article-title":"Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis","volume":"28","author":"Clark","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctarc.2017.11.007_bib52","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1016\/j.ijrobp.2008.06.1312","article-title":"Defining the standard of care;waiting times, data recording. adverse effects reporting, radiotherapy compliance and follow up of head and neck cancer patients, at a tertiary care center in India","volume":"72","author":"Bajpai","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2017.11.007_bib53","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00066-012-0156-6","article-title":"Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients","volume":"188","author":"Kirchheiner","year":"2012","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2012.05.007","article-title":"Late gastrointestinal and urogenital side-effects after radiotherapy--incidence and prevalence. Subgroup-analysis within the prospective Austrian-German phase II multicenter trial for localized prostate cancer","volume":"104","author":"Schmid","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2017.11.007_bib55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.ijrobp.2007.04.054","article-title":"Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency","volume":"69","author":"Davidson","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294217300515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294217300515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:17:33Z","timestamp":1762841853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294217300515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":55,"alternative-id":["S2468294217300515"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2017.11.007","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative assessment of late toxicity in patients of carcinoma cervix treated by radiotherapy versus chemo-radiotherapy \u2013 Minimum 5 years follow up","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}